We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Karuna Therapeutics Inc | NASDAQ:KRTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 329.83 | 301.63 | 329.99 | 0 | 01:00:00 |
Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that senior management will participate in the following upcoming virtual investor conferences:
William Blair’s Biotech Focus Conference Date: Thursday, August 6, 2020 Time: 10:00 a.m. EDT
Wedbush PacGrow Healthcare Virtual Conference Date: Tuesday, August 11, 2020 Time: 10:55 a.m. EDT
Canaccord Genuity 40th Annual Growth Conference Date: Wednesday, August 12, 2020 Time: 4:00 p.m. EDT
JMP Securities CNS Forum Date: Wednesday, August 19, 2020 Time: 11:30 a.m. EDT
A live webcast of the Wedbush presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 90 days on Karuna’s website following the conference.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric and pain management patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005169/en/
Investor Contact Alexis Smith 518-338-8990 asmith@karunatx.com
1 Year Karuna Therapeutics Chart |
1 Month Karuna Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions